Intra-Cellular Therapies, Inc. (ITCI)
USD 131.87
(0.0%)
USD 131.87
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -124.19 Million | -270.18 Million | -259.54 Million | -230.07 Million | -127.98 Million | -118.16 Million |
| Net Income | -139.67 Million | -256.25 Million | -284.12 Million | -227 Million | -147.72 Million | -155.12 Million |
| Depreciation & Amortization | 528 Thousand | 656 Thousand | 533.36 Thousand | 528.11 Thousand | 477.12 Thousand | 368.67 Thousand |
| Deferred income taxes | -8.4 Million | - | -4.07 Million | -648.24 Thousand | -1.13 Million | 529.21 Million |
| Stock-based compensation | 52.83 Million | 43.01 Million | 34.3 Million | 24.11 Million | 20.78 Million | 17.39 Million |
| Change in working capital | -29.57 Million | -58.13 Million | -6.35 Million | -27.27 Million | -589.48 Thousand | 19.94 Million |
| Other non-cash items | 92 Thousand | 537 Thousand | 178.53 Thousand | 214.1 Thousand | 194.2 Thousand | -529.96 Million |
| Investing Cash Flow | 105.54 Million | -128.37 Million | 280.34 Million | -480.29 Million | 177.43 Million | 134.64 Million |
| Investments in PPE | -269 Thousand | -778 Thousand | -325.73 Thousand | -266.72 Thousand | -700.39 Thousand | -391.26 Thousand |
| Acquisitions | - | 127.59 Million | -280.66 Million | 480.02 Million | -178.13 Million | - |
| Investment purchases | -415.26 Million | -759.2 Million | -224.57 Million | -755.62 Million | -80.72 Million | -271.15 Million |
| Sales/Maturities of investments | 521.07 Million | 631.61 Million | 505.24 Million | 275.6 Million | 258.85 Million | 406.18 Million |
| Other Investing Activities | 105.81 Million | -127.59 Million | 280.66 Million | -480.02 Million | 178.13 Million | 135.03 Million |
| Financing Cash Flow | 17.81 Million | 455.15 Million | 11.51 Million | 664.17 Million | 3.23 Million | 685.18 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 17.81 Million | 455.15 Million | 11.51 Million | 652.71 Million | 3.23 Million | 685.18 Thousand |
| Other Financing Activities | 17.81 Million | 455.15 Million | 11.51 Million | 11.46 Million | 3.23 Million | 685.18 Thousand |
| Accounts receivables | -38.82 Million | -55.03 Million | -9.39 Million | -10.76 Million | - | - |
| Accounts payables | 1.05 Million | 1.7 Million | 3.18 Million | -1.92 Million | -6.53 Million | 7.78 Million |
| Inventory | -26.34 Million | -15.97 Million | -891.74 Thousand | -7.05 Million | - | - |
| Other working capital | 34.54 Million | 11.16 Million | 740.84 Thousand | -7.53 Million | 5.94 Million | 12.15 Million |
| Cash at beginning of period | 150.36 Million | 93.76 Million | 61.44 Million | 107.63 Million | 54.94 Million | 37.79 Million |
| Cash at end of period | 149.51 Million | 150.36 Million | 93.76 Million | 61.44 Million | 107.63 Million | 54.94 Million |
| Capital Expenditure | -269 Thousand | -778 Thousand | -325.73 Thousand | -266.72 Thousand | -700.39 Thousand | -391.26 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -848 Thousand | 56.6 Million | 32.31 Million | -46.19 Million | 52.68 Million | 17.15 Million |
| Free Cash Flow | -124.46 Million | -270.96 Million | -259.86 Million | -230.33 Million | -128.68 Million | -118.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26.32 Million | -16.21 Million | -15.24 Million | -28.57 Million | -139.67 Million | -24.25 Million |
| Depreciation & Amortization | 138 Thousand | 129 Thousand | 132 Thousand | 136 Thousand | 528 Thousand | 135 Thousand |
| Deferred income taxes | - | - | - | -2.53 Million | -8.4 Million | -2.19 Million |
| Stock-based compensation | 17.48 Million | 16.37 Million | 13.84 Million | 14.85 Million | 52.83 Million | 14.31 Million |
| Change in working capital | -15.99 Million | 2.09 Million | -30.52 Million | 14.04 Million | -29.57 Million | -13.29 Million |
| Other non-cash items | -1.82 Million | 25.21 Million | 29.34 Million | 23 Thousand | 92 Thousand | 24 Thousand |
| Investing Cash Flow | -209.2 Million | 7.76 Million | 16.17 Million | 47.42 Million | 105.54 Million | -20.16 Million |
| Investments in PPE | -696 Thousand | -53 Thousand | - | -1000.00 | -269 Thousand | -268 Thousand |
| Acquisitions | - | - | - | -19.89 Million | - | 19.89 Million |
| Investment purchases | -312.5 Million | -88.52 Million | -81.04 Million | -104.46 Million | -415.26 Million | -136.39 Million |
| Sales/Maturities of investments | 104 Million | 96.34 Million | 97.22 Million | 151.88 Million | 521.07 Million | 116.49 Million |
| Other Investing Activities | 1.00 | 7.81 Million | 16.17 Million | 47.42 Million | 105.81 Million | -19.89 Million |
| Financing Cash Flow | 6.73 Million | 545.17 Million | 9.98 Million | 3 Million | 17.81 Million | 2.58 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -12.08 Million | 545.17 Million | 9.98 Million | 3 Million | 17.81 Million | 2.58 Million |
| Other Financing Activities | 6.73 Million | 545.17 Million | 9.98 Million | 3 Million | 17.81 Million | 2.58 Million |
| Accounts receivables | 106 Thousand | -14.55 Million | -17.13 Million | -11.34 Million | -38.82 Million | -6.7 Million |
| Accounts payables | -7.21 Million | 6.01 Million | 80 Thousand | 839 Thousand | 1.05 Million | 2.88 Million |
| Inventory | -1.37 Million | -1.87 Million | -499 Thousand | -7.28 Million | -26.34 Million | -1.09 Million |
| Other working capital | -7.52 Million | 12.51 Million | -12.96 Million | 31.83 Million | 34.54 Million | -8.37 Million |
| Cash at beginning of period | 695.05 Million | 141.56 Million | 149.51 Million | 101.15 Million | 150.36 Million | 144 Million |
| Cash at end of period | 466.06 Million | 695.05 Million | 141.56 Million | 149.51 Million | 149.51 Million | 101.15 Million |
| Capital Expenditure | -696 Thousand | -53 Thousand | - | -1000.00 | -269 Thousand | -268 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -228.99 Million | 553.48 Million | -7.94 Million | 48.36 Million | -848 Thousand | -42.85 Million |
| Free Cash Flow | -27.22 Million | 489 Thousand | -34.11 Million | -2.06 Million | -124.46 Million | -25.53 Million |
WIPL
AWC
MEKKO
CBBI
PSAN
6246